LeafCann boss warns on adult-use move by Martin Lane August 23, 2022August 23, 2022 LeafCann CEO Elisabetta Faenza has warned adult-use legalisation could see investment drain away from the medicinal […]
ACannabis is back, with an exclusive offer for Cannabiz members by cannabiz team February 8, 2022February 10, 2022
Confusion reigns over TGA changes to Special Access and Authorised Prescriber schemes by Rhys Cohen November 18, 2021November 23, 2021
Company news: LeafCann; LGP; Cannim; Roto-Gro; MGC Pharma; ECS Botanics by Martin Lane October 28, 2021October 28, 2021
Post-Brexit Britain and the rivers of green for Australian cannabis companies by Martin Lane June 9, 2021April 26, 2024
FreshLeaf to unveil latest findings via exclusive webinar by Martin Lane March 24, 2021April 26, 2024
‘Reputation arrives on foot, and leaves on horseback’: industry urged not to rush to profitability by Steve Jones March 18, 2021April 26, 2024
Exclusive Cannabiz member offer: 20% off ACannabis EVOLVE tickets by Martin Lane February 9, 2021April 26, 2024
Exclusive: Department of Health considers making imported medical cannabis meet GMP standards by Rhys Cohen October 6, 2020April 26, 2024
Put patients first and the whole industry will thrive by Steve Jones September 26, 2020April 26, 2024